A clinical appraisal of methenamine hippurate in urinary tract infections.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D003556:Cystitis / Q000150:complications; D005260:Female; D006626:Hippurates / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008709:Methenamine / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D008875:Middle Aged; D011704:Pyelonephritis / Q000150:complications; D014514:Ureteral Calculi / Q000150:complications; D014517:Ureteral Obstruction / Q000150:complications; D014545:Urinary Calculi / Q000150:complications; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000209:etiology
D006626:Hippurates; D008709:Methenamine